Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society, Osteoarthritis and Cartilage, vol.4, issue.4, pp.217-260, 1996. ,
DOI : 10.1016/S1063-4584(05)80101-3
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III, J Rheumatol, vol.24, issue.4, pp.799-802, 1997. ,
Interpreting Health-Related Quality of Life Scores, Medical Care, vol.41, issue.5, pp.597-605, 2003. ,
DOI : 10.1097/00005650-200305000-00006
Many faces of the minimal clinically important difference ,
Defining clinically meaningful change in health-related quality of life, Journal of Clinical Epidemiology, vol.56, issue.5, pp.395-407, 2003. ,
DOI : 10.1016/S0895-4356(03)00044-1
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.29-33, 2005. ,
DOI : 10.1136/ard.2004.022905
Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening, Quality of Life Research, vol.11, issue.3, pp.207-228, 2002. ,
DOI : 10.1023/A:1015276414526
Reassessing Quality-of-Life Instruments in the Evaluation of New Drugs, PharmacoEconomics, vol.12, issue.6 ,
DOI : 10.2165/00019053-199712060-00002
Measurement of fatigue: Determining minimally important clinical differences, Clinical Therapeutics, vol.24, issue.3, pp.239-283, 2002. ,
DOI : 10.1016/S0149-2918(02)85097-4
Measurement of health status, Controlled Clinical Trials, vol.10, issue.4, pp.407-422, 1989. ,
DOI : 10.1016/0197-2456(89)90005-6
Determining a minimal important change in a disease-specific quality of life questionnaire, Journal of Clinical Epidemiology, vol.47, issue.1, pp.81-88, 1994. ,
DOI : 10.1016/0895-4356(94)90036-1
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.34-41, 2005. ,
DOI : 10.1136/ard.2004.023028
Feeling good rather than feeling better matters more to patients, Arthritis & Rheumatism, vol.5, issue.4, pp.526-556, 2006. ,
DOI : 10.1002/art.22110
The Cost of Dichotomization, Applied Psychological Measurement, vol.7, issue.3, pp.249-53, 1983. ,
DOI : 10.1177/014662168300700301
The cost of dichotomising continuous variables, BMJ, vol.332, issue.7549, p.1080, 2006. ,
DOI : 10.1136/bmj.332.7549.1080
How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure ,
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations, Pain, vol.113, issue.1, pp.69-189, 2005. ,
DOI : 10.1016/j.pain.2004.09.012
Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders, J Rheumatol, vol.34, issue.5, pp.1188-93, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00155664
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues, J Rheumatol, vol.32, issue.10, pp.2025-2034, 2005. ,
Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, The Journal of Rheumatology, vol.37, issue.1, pp.26-31, 2009. ,
DOI : 10.3899/jrheum.090449
Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis, Arthritis & Rheumatism, vol.30, issue.6, pp.960-963, 2006. ,
DOI : 10.1002/art.22342
Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient???s perspective, Pain, vol.121, issue.1, pp.151-158, 2006. ,
DOI : 10.1016/j.pain.2005.12.021
Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial, Arthritis & Rheumatism, vol.52, issue.4, pp.553-60, 2008. ,
DOI : 10.1002/art.23527
Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics, Arthritis Care & Research, vol.60, issue.Suppl, pp.826-860, 2010. ,
DOI : 10.1002/acr.20131
Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis, Arthritis & Rheumatism, vol.62, issue.1, pp.133-142, 2007. ,
DOI : 10.1002/art.22469
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis 28. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria, Arthritis Rheum. Arthritis Rheum, vol.3127, issue.34, pp.315-24361, 1984. ,
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand, Arthritis & Rheumatism, vol.62, issue.11, pp.1601-1611, 1990. ,
DOI : 10.1002/art.1780331101
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip, Arthritis & Rheumatism, vol.29, issue.5, pp.505-519, 1991. ,
DOI : 10.1002/art.1780340502
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Measurement of patient outcome in arthritis, Arthritis Rheum. Arthritis Rheum, vol.2923, issue.322, pp.1039-49137, 1980. ,
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, vol.21, issue.12, pp.2286-91, 1994. ,
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index, J Rheumatol, vol.21, issue.12, pp.2281-2286, 1994. ,
Validity, factor structure, and clinical relevance of the AUSCAN osteoarthritis hand index, Arthritis Rheum, vol.54, issue.2, pp.551-557, 2006. ,
Validation of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthitis of the hip or knee, J Rheumatol, vol.15, pp.1833-1873, 1995. ,
A Study of the Natural History of Back Pain, Spine, vol.8, issue.2, pp.141-145, 1983. ,
DOI : 10.1097/00007632-198303000-00004
Minimal clinically important difference module: summary, recommendations, and research agenda, J Rheumatol, vol.28, issue.2, pp.452-456, 2001. ,
1110-1. 40 The variability in MCII and PASS estimates did not have an impact on treatment effect estimates Which chronic conditions are associated with better or poorer quality of life? Comparison of transformed visual analogue and native numerical rating scaled patient responses to the WOMAC Index, Disease Activity State in Rheumatoid Arthritis)):23. 43. Wells G al. MCID/Low Disease Activity State Workshop: Summary, Recommendations, and Research Agenda, pp.725-8895, 2000. ,